Skip to main content
Nature Communications logoLink to Nature Communications
. 2026 Sep 30;17:10363. doi: 10.1038/s41467-026-78144-1

Programmable DNA protonuclei reveal environmental context on protein phase separation

Johann Fritzen 1, Avik Samanta 2, Nele S Kuhr 3, Antonia Preuß 3,4, Erin L Sternburg 3, Lukas S Stelzl 3,4, Jasper J Michels 5,✉, Dorothee Dormann 3,4,✉, Andreas Walther 1,5,✉
PMCID: PMC13627716  PMID: 42816535

Abstract

Understanding protein phase separation in cellular environments remains a major challenge, as ex vivo assays often fail to capture the influence of environmental context – such as crowding, multimodal interactions, and the dynamic properties of the cytosol or nucleus. Here, we introduce programmable DNA-based protonuclei (PN) as nucleus-inspired compartments to probe phase separation of the neurodegeneration-linked protein FUS. We show that FUS partitioning and condensate formation are highly sensitive to nucleic acid sequence, spatial confinement, and viscoelastic properties of the PN core. Notably, classical test-tube affinity assays fail to predict protein behavior within the crowded and multivalent PN environment. By tuning DNA crosslinking, we modulate condensate dynamics and suppress liquid-to-solid transitions of FUS – a hallmark of disease. These findings demonstrate that multivalent, confined environments fundamentally reshape protein-nucleic acid interactions and phase behavior. The PN platform complements test-tube assays and complex cellular settings and enables to dissect nuclear condensates under controllable conditions.

Subject terms: Synthetic biology, Polymer chemistry, DNA nanostructures


Protein phase separation is often investigated in dilute solution, meaning that the influence of the crowded environmental context of cells is often overlooked. Here, the authors introduce a programmable DNA-based platform to probe the phase behavior of proteins within a more biomimetic environment.

Introduction

Phase separation (PS) leading to biomolecular condensates plays a key role in cell regulation, organization, and stress response.1–3 Many of such condensates are formed by protein and nucleic acid components, for instance, the nucleolus, Cajal bodies, paraspeckles, and nuclear speckles in the cell nucleus, and stress granules or P-bodies in the cytoplasm.4 Understanding such protein/nucleic acid condensates is of critical importance to further our knowledge about disease development and cellular regulatory processes, which is particularly challenging for condensates formed by multiple components and occurring in complex and nucleic acid-rich environments, such as the nucleus. Indeed, the nucleus presents a unique environment comprising numerous RNA/protein- and chromatin-based condensates whose assembly and material properties are governed by high nucleic-acid content, transcriptional activity, and viscoelastic chromatin constraints.4,5

One key problem is the translatability of facile test-tube solution experiments to in cellulo situations.6 Simple solution investigations benefit from high throughput and widely tunable conditions, and have the potential to speed up mechanistic understanding due to reductionist settings. However, such systems rarely capture the complexity of the cellular environment, which is not only crowded but also compositionally and mechanically heterogeneous. This discrepancy limits the translatability of insights gained from dilute solution assays to real biological function. The addition of molecular crowders has been one approach to arrive at situations mimicking more closely the crowded cellular environment. Nonetheless, some crowders influence PS beyond their crowding contribution,7,8 partition into condensates9–11 or change condensate properties at high concentrations.12 Beyond these limitations, such conditions cannot replicate anything vaguely reminiscent of the cell nucleus, for which it would be very beneficial to have tunable ex cellulo model systems.

A particular gap exists in understanding how nucleic acid sequence, spatial confinement, and material state jointly shape PS of biopolymers–a triad that remains unaddressable thus far in conventional approaches. A system that allows precise control over these factors could provide critical insights into the mechanisms of nuclear PS, especially for proteins that are implicated in disease, such as neurodegenerative diseases and cancer, through misregulated condensation.13,14 Importantly, several RNA-binding proteins implicated in neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), including Fused in sarcoma (FUS) and TDP-43, form nuclear condensates in vivo15 and occasionally form pathological aggregates in the nucleus.16 FUS undergoes PS at sites of DNA double-strand breaks, where FUS-dependent PS is required for the recruitment of DNA repair factors and higher-order clustering of chromatin nanodomains. This identifies chromatin‑associated, nucleic acid-rich and mechanically constrained nuclear environments as critical regulators of FUS condensate function.17

We hypothesized that a critical cross-fertilization of the field of biological PS would be possible by transferring concepts from all-DNA artificial cells18–22 to study condensate formation processes in tailored nucleus-inspired environments. Such synthetic structures are built entirely from DNA and are tunable in composition, structure and viscoelastic properties. To this end, we introduce here a protonucleus (PN) platform as a bottom-up, programmable DNA-rich compartment system that complements classical test tube/solution experiments and in cellulo studies. We explore this system for a model protein implicated in neurodegenerative disease–the FUS protein–which is known to undergo PS and to bind to nucleic acids.23–26 We find that the recruitment and PS of FUS is not only highly dependent on DNA and RNA sequence, but that classical ex vivo methods such as electrophoretic mobility shift assays (EMSA) cannot fully predict the interactions found in crowded and restrained DNA PN environments. Additionally, we show that the dynamic/viscoelastic properties of the PN significantly influence PS of FUS to the point of full suppression. Our in protonucleo method based on a tunable DNA nanoscience approach introduces a highly versatile platform that complements simple in solution ex vivo assays and in cellulo studies.

Results

Synthetic all-DNA PN as a protein PS platform

The PN builds on our work on DNA-based core-shell particles formed by temperature-induced PS of two long ssDNA multiblock copolymers, namely p(A20-m) and p(T20-n).19,21,22,27–29 Therein, A20 and T20 correspond to homo-repeats of adenine and thymine nucleobases, respectively, and m and n are ssDNA barcodes that allow for functionalization (sequences in Fig. 1a and Supplementary Table 1). In short, PN form by selective PS of p(A20-m) during heating, whereafter p(T20-n) hybridizes during cooling onto the phase-separated droplets, stabilizing them at the core/shell interface by multivalent A20/T20 duplexes (Fig. 1a). The resulting PN has a kinetically trapped, liquid pool of long ssDNA inside. The DNA concentration is 5–13 g/L, which approximates that of the nucleus in a cell of about 9–31 g/L (Supplementary Table 2). The PN shell is highly permeable and allows for the uptake of macromolecules, such as proteins.27

Fig. 1. PN platform and biological relevance of FUS PS.

Fig. 1

a Simplified preparation of our PN platform and the relevant addressable domains m, n and A20. b Schematic comparison of FUS in a healthy neuron to the FUS pathology in ALS and FTD. c The general workflow of a PS experiment with MBP-FUS-GFP (soluble) and all-DNA PN, encompassing protein loading, MBP-tag cleavage, and microscopic visualization of FUS PS inside PN.

To apply the PN system to a biologically and disease-relevant model system, we selected the FUS protein because it is a very well-studied nucleic acid-binding protein.25,26,30 In cells, FUS is involved in splicing, DNA damage repair, transcription regulation, RNA transport and translation regulation.31–34 FUS is mostly located in the nucleus of healthy cells, but can be mislocalized to the cytoplasm of nerve cells because of mutations in the nuclear localization signal (NLS), or other defects in Transportin-1 (TNPO1)-mediated nuclear import of FUS (Fig. 1b).33,35–37 Cytosolic FUS phase separates over time and FUS condensates undergo an irreversible liquid-to-solid transition to a non-functional amyloid-like state,23,38–40 implicated in neurodegenerative diseases, such as ALS and FTD.41–43

Figure 1c visualizes the general workflow. We use recombinantly produced full-length FUS with a C-terminal eGFP tag for fluorescence imaging by confocal laser scanning microscopy (CLSM), as well as an N-terminal protease-cleavable maltose-binding protein (MBP) tag for enhanced solubility and initial suppression of PS. This strategy allows to introduce MBP-FUS-GFP into PN in a soluble state, and, once the sample is equilibrated, to trigger PS of FUS by cleaving off the MBP tag with TEV protease. Control experiments using isolated MBP and TEV protease confirm that these components and their combination do not induce PS of the PN core (see Supplementary Fig. 1–3).

FUS loading ratio controls PS morphology

We first investigate the influence of FUS-GFP concentration on the PS behavior. In these experiments we use pristine PN only labeled at their shell with n*Atto565 to visualize the shell in CLSM (magenta channel). The ratio of FUS-GFP to repeating units (r.u.) of p(A20-m) describes the increased loading of FUS-GFP into the PN. Partitioning values for each loading ratio (LR) and fluorescence recovery after photobleaching (FRAP) of FUS-GFP before MBP-cleavage are shown in Supplementary Note 4 (Supplementary Fig. 4 and 5). Figure 2 depicts three major domain windows that occur at different FUS-GFP/p(A20-m) ratios of 0.10 to 1.50. We have chosen representative snapshots of intermediate morphologies (0–30 min) and end state morphology (5 h) of the FUS PS process. At a low LR (≲0.30), phase-separated FUS-GFP droplets appear within the PN, resembling a binodal domain. Binodal PS takes place in the metastable boundary region of the phase diagram. It requires fluctuations to nucleate PS, which usually leads to a droplet morphology by growth and coalescence. In contrast, spinodal decomposition happens spontaneously and rapidly for more concentrated solutions in the center of the phase diagram. This typically leads to co-continuous morphologies that coarsen and can also form a single domain at the end of the PS process.44–47 Interestingly, for LRs between approximately 0.60 and 0.90, a co-continuous morphology occurs that is reminiscent of the spinodal domain. Key morphological features include surface-directed spinodal decomposition, characterized by formation of a wetting layer at the p(A20-m)/p(T20-n) interface followed by a depletion layer. This pattern repeats throughout the condensate, generating co-continuous structures with a characteristic length scale. Over time, continued coarsening and merging of these domains give rise to a single condensate (Fig. 2, end state). Finally, at high LRs (≳ 1.20) the dilute phase forms droplets within the dense phase, marking the inverted region of the phase diagram.

Fig. 2. Different ratios of FUS-GFP to core repeating unit of p(A20-m) of PN lead to diverse PS morphologies.

Fig. 2

The PN shell is shown in the magenta channel, FUS-GFP is in green. Imaging of the samples was done continuously for the initial 30 min, with representative snapshots shown as “intermediate state”. Snapshots shown as “end state” are at 5 h after TEV addition. Overview images are shown in Supplementary Fig. 6. Additionally, the initial PS can be viewed in Supplementary Movie 1. The repeat sequence of p(A20-m) is shown in Fig. 1a. Scale bar = 1 µm.

Continuum model predicts FUS phase behavior in PN

To rationalize and predict FUS phase behavior in multicomponent mixtures, we next introduce a continuum model. The model (details in Supplementary Note 5) treats the PN and their contents as order parameter fields, whose spatiotemporal variations are governed by minimization of a free energy. For a solution containing m−1 solutes (m indexing the solvent) in the presence of n PN, this free energy is written as a function of sets of conserved (volume fractions) c1≤i≤mr and non-conserved order parameters φ1≤k≤nr as:

Fci,φk=FCH+Fcom+Frep+Fmix 1

The order parameter φk represents the kth PN and assumes values of 1, 0 and 0 < φk < 1 in its interior, exterior and boundary region. Equation (1) comprises a Cahn-Hilliard free energy (FCH), a contribution due to PN compressibility (Fcom), a penalty (Frep) associated with spatial overlap between PN, and a Flory-Huggins-type mixing free energy (Fmix), which are detailed in Supplementary Note 5.1. The evolution equations for the concentrations and PN are:

∂ci<mr∂t+us⋅∇ci=∑j=1m−1∇⋅Λij∇δFc,φδcij+ζir 2
∂φkr∂t+uk⋅∇φk+φk∇⋅uk=−ΓδFc,φδφk 3

with ukr the local velocity in each phase field and us the divergence-free (solenoidal) component of the total velocity field (∑k=1nuk). Under the assumption of overdamped dynamics, we relate the local velocity to a thermodynamic restoring force as ukr=ξ−1δFc,φδφk∇φkr, with ξ a friction coefficient associated with PN motion. Γ and Λij are kinetic and mobility coefficients, governing the dynamics of, respectively, the non-conserved and conserved order parameter fields, the latter being subject to delta-correlated noise represented by ζir, numerically implemented as described previously48,49.

By numerically solving the dynamic Eqs. (2) and (3), we simulate FUS co-PS in PN at various LRs. A calculation comprises two stages: (i) a generation stage and (ii) a quenching stage. In the generation stage, the MBP-FUS loaded PN are formed. To this end, we nucleate the PN in a homogeneous ternary mixture comprising generic “DNA” (e.g., p(A20-m)), “MBP-FUS” and “solvent”, whereupon the components partition across the PN exterior (α-phase) and interior (β-phase), dictated by binary interaction parameters χijα and χijβ. DNA strongly partitions inside the PN as we set χDNA−solventα » χDNA−solventβ. In contrast, the MBP-FUS is expected to have the same interaction with the solvent inside and outside the PN, so χFUSMBP−solventα = χFUSMBP−solventβ but should preferentially locate inside the PN on account of its DNA binding property: χDNA−FUSMBPα = χDNA−FUSMBPβ « 0. Uptake of MBP-FUS is further driven by assuming marginal solvent conditions, evaluating χFUSMBP−solventα and χFUSMBP−solventβ just below their critical value. All values of the interaction parameters in the generation stage are given in Fig. 3a and listed in Supplementary Tables 3 and 4.

Fig. 3. Interaction matrices and calculated ternary phase diagrams.

Fig. 3

a, b color scale representation of the Flory-Huggins interaction parameters in the generation stage and quenching stage, respectively, i.e., for DNA:MBP-FUS:solvent and DNA:FUS:solvent outside (left) and inside (right) the PN. c Ternary phase diagrams, calculated by equating chemical potentials and osmotic pressures in/of coexisting phases using previously reported methods.69–71 The diagrams show the considerable increase of the miscibility gap upon cleaving the MBP tag: the light gray and dark gray phase diagrams respectively correspond to DNA:MBP-FUS:solvent and DNA:FUS:solvent (spinodal: dotted lines, binodal: solid lines). The solid green arrow indicates the approximate core concentration in each PN (0.21) and how the LR increases with the FUS concentration inside the PN. Source data are provided as a Source Data file.

In the quenching stage we numerically simulate the co-PS of FUS and DNA upon removing the MBP tag. We directly target correct co-PS, because, as we will see below, DNA in fact co-phase separates with FUS in the PS process in pristine PN. MBP removal is achieved by subjecting the loaded PN formed in the generation stage to a stepwise increase in χFUSMBP−solvent, which logically becomes χFUS−solvent (see Fig. 3b and Supplementary Table 3). For simplicity, we do not consider the cleaved MBP tag as an additional component, nor do we consider changes in molecular volume. Naturally, the increase applies to the interior as well as the exterior of the PN and causes a drastic change in the phase diagram: the small miscibility gap encountered for DNA:MBP-FUS:solvent widens significantly (see Fig. 3c), pushing the phase boundaries in opposite directions. This gives rise to coexistence between a dense phase, enriched in FUS + DNA and a solvent-rich phase nearly depleted in FUS but containing a fraction of DNA. As a result of the expansion in the miscibility gap, compositions that were formerly in a single-phase region now find themselves in a coexistence region, which leads to PS inside the PN.

Figure 4a and Supplementary Movie 2 show how three PN nucleated in a homogeneous solution of DNA and MBP-FUS grow to reach their equilibrium size while repelling each other to avoid spatial overlap. Figure 4b shows numerically simulated phase-separated early-time morphologies in the quenching stage for a constant mean DNA concentration of c¯DNAβ ~0.21 (see green arrow in Fig. 3c) and increasing loading of FUS(-MBP) (left to right). The evolution of the morphologies is in agreement with the experiments (Fig. 2). When increasing the LR, the dense phase first organizes in droplets, then becomes a co-continuous regime, before crossing over into a phase-inverted morphology for LR » 1. This corresponds to the binodal, spinodal and inverted phase regimes. Furthermore, equally in agreement with the experiments, assuming a mild short-range attraction between DNA and the interior wall of the PN (details in Supplementary Note 5.2) gives rise to a surface enrichment of the dense phase and surface-directed PS (see e.g., LR = 0.8, 1). Collectively, these numerical simulations explain and fundamentally validate the experimentally observed morphologies on account of solid PS theory in multicomponent mixtures.

Fig. 4. Numerical simulations.

Fig. 4

a Exemplary PN generation at LR = 0.65 (see Supplementary Movie 2). Droplets become more spherical due to ongoing PS and partitioning of MBP-FUS. The time domain is 2048 dimensionless time units. b PS intermediate stages with morphology snapshot of DNA:FUS co-PS inside PN, triggered by removing the MBP tag as a function of the LR. The time domain is 40 dimensionless units for LR = 0.37 and 16 dimensionless units for the higher LRs (see Supplementary Movie 3).

PN core sequence modifications affect FUS partitioning

One of the strengths of the PN system is the ease of functionalizing them with additional nucleic acids (either DNA or RNA oligonucleotides) via their m barcodes or A20 domains to understand how variations in PN core composition impact affinity and PS. This is schematically shown in Fig. 5a for six samples: The pristine PN (1) is the only sample without core modification, meaning both m and A20 domains are not hybridized. This is different for the next two samples, where ssDNA strands complementary to m are added (sequences in Fig. 5b): (2) m*Atto647N forms m/m*Atto647N DNA duplexes. (3) m*-RNACy5 is a complementary RNA leading to an m/m* DNA/RNA duplex with a dangling RNA strand (39 nt in length). The remaining samples are structured analogously, with the difference of utilizing the A20 domain for hybridization: (4) T20Atto647N forms a simple A20/T20Atto647N DNA duplex. (5) U20-RNACy5 forms a A20/U20 duplex with a dangling RNA strand. (6) T20-mAtto647N has a dangling m as additional ssDNA overhang, effectively doubling [m] in the PN core. As RNA overhang in both RNA-containing samples, we chose a physiologically relevant RNA with high affinity to FUS.25,50 All these modifiers are tightly bonded to the PN via dsDNA or DNA/RNA bonding, with melting temperatures, Tm, in experimental buffer exceeding 60 °C (calculated Tm in Supplementary Fig. 7). All experiments use a LR of 0.30, hence a regime where the pristine PN/FUS-GFP system is in the binodal domain (Fig. 2). We chose this concentration regime to ensure an excess of the introduced nucleic acid sequences compared to FUS-GFP.

Fig. 5. Modification of the PN core sequences alters partitioning and PS behavior.

Fig. 5

a Schematic illustration of the two PN core modification strategies used in the experiments. b DNA (2, 4, 6, uppercase) and RNA (3, 5, lowercase) sequences used for core modification. c CLSM snapshots of single PN with different DNA/RNA modifications after defined time intervals of 5 min, 30 min, 5 h, 1 day and 2 days. FUS-GFP in green, core modifications in magenta and shell in yellow channel. White arrows indicate condensates with core segregation, see Supplementary Figs. 9, 10. PN have average diameters from 3.7–4.7 µm. We scaled representative PN examples to full panel size for clarity. For overview images with indication of the selected PN, see Supplementary Figs. 11, 12. Scale bar = 1 µm. d Example of manual PN segmentation in sample T20Atto647N-PN to measure PN diameter and partition coefficient P of MBP-FUS-GFP. Scale bar = 5 µm. Violin plots: diameter distribution and partition coefficient of FUS from 2D CLSM: Box shows interquartile range (IQR), whiskers to 1.5 x IQR, outliers in magenta, mean as orange line, median as white circle. N = 146, 92, 92, 91, 83, 79 (left to right). N denotes the number of individual PN compartments. e EMSAs of all relevant DNA/RNA sequences to probe their binding to MBP-FUS. The experiment was performed twice with similar results. f FRAP of the pA-based core material of the PN of all samples with dye-containing core modifications before MBP-FUS-GFP addition. Note that the pristine PN (1) does not have a dye modification. See Supplementary Figs. 13, 14 for FRAP details. N=1 per core modification. g FRAP of m*RNACy5-PN after 1 day for both the core and FUS channel. The plotted result is the mean of two ROIs (see inset) from distinct condensates within one PN. Scale bar = 1 µm. Loading ratio is 0.30 for all experiments. Source data are provided as a Source Data file.

Experimentally, we monitored the evolution of FUS PS over time through CLSM. Figure 5c shows single PN before TEV addition (boxed region) and at different time points after TEV addition (overview images in Supplementary Fig. 8). The mean diameters of all PN range from 3.7 to 4.7 µm (Fig. 5d), thus slightly smaller but comparable in scale to human cell nuclei with an average diameter of about 6 µm.51

We first quantify the partitioning of MBP-FUS-GFP into PN before initiation of PS by comparing the mean GFP intensity inside the PN core with that of the solution (background; Fig. 5d). The equilibrated PN show different levels of protein partitioning. Pristine PN (1) and T20Atto647N-PN (4) exceed the other samples by far. Both RNA-containing PN (3: m*-RNACy5, 5: U20-RNACy5) and T20-mAtto647N-PN (6) show moderate MBP-FUS-GFP partitioning, whereas the weakest partitioning is observed for m*Atto647N-PN (2).

Since partitioning is expected to scale with affinity, we semi-quantitatively assessed binding of FUS to the different nucleic acid sequences using electrophoretic mobility shift assays (EMSA, Fig. 5e). EMSA demonstrates a moderate affinity of FUS for all DNA sequences except A20, which is a poor FUS binder (Fig. 5e, left). Poor A20-FUS binding can be explained by the strong base stacking behavior known for p(A),52,53 limiting its availability for FUS binding, which we also identify in atomistic molecular dynamics simulations between A20 and a nucleic acid-binding part of FUS (Supplementary Note 11, Supplementary Fig. 15, 16 and Supplementary Table 5). A comparison of a moderate binder (m) and a strong binder (3: m*-RNACy5) at lower FUS concentration shows the far superior binding affinity of the latter, in line with the known high RNA/FUS affinity for this particular RNA25,50 (Fig. 5e, right).

Comparing the EMSA data to the partitioning data, some trends carry over, such as binding of FUS-GFP is stronger for PN functionalized with RNA sequences such as m*-RNACy5 (3), U20-RNACy5 (5) compared to PN simply functionalized with m*Atto647N (2). However, other EMSA results are in stark contrast to the partitioning data. Pristine PN (1) and T20Atto647N-PN (4) do not carry the strongly binding RNA sequence and yet show the highest partitioning values. Most interestingly, m/m*Atto647N (2) shows high binding affinity in EMSA, but the lowest partitioning on the PN level. The highest partitioning can be found for T20Atto647N-PN (4) with pristine m barcode, but with hybridized A20/T20 sequences. Taken together, these experiments highlight the impact of environmental parameters on nucleic acid/FUS interactions. Most critically, standard in-solution EMSA affinity measurements deliver in parts completely different interaction maps compared to the crowded and DNA-rich PN environment. The most significant disparity can be identified for the comparison of T20Atto647N (4, P = 743) and m*Atto647N (2, P = 36) with a ca. 20-fold difference in partitioning (Fig. 5d), although both duplexes display similar EMSA affinities (Fig. 5e, columns A20/T20 and m/m*).

PN core modifications alter dynamics and condensate morphology

Next, we turn to kinetic details of FUS-GFP PS in these differently functionalized PN, after initiating PS by cleavage of the MBP-tag with TEV protease. Note that TEV cleavage is a rapid process, completed within less than two min in buffered solution (Supplementary Fig. 17). In pristine PN (1), PS starts also quickly, with FUS-GFP droplet formation occurring within five min after MBP cleavage and subsequent wetting of the inner surface of the PN shell after a few hours (Fig. 5c, left). Additionally, the remaining droplets increase in size due to coalescence. Over the course of 1–2 days the wetting region gains in thickness due to coalescence of FUS-GFP droplets with the FUS-GFP shell. We further comment on the formation of the concentric shell below for dye-labeled PN.

Introduction of m*Atto647N (2) leads to key differences in the PS behavior of FUS-GFP. Hardly any FUS-GFP droplets form in the initial 30 minutes after TEV cleavage within the PN. Afterwards droplets are formed inside and on the outside surface of the PN. Note, that m*Atto647N (2) visualizes the PN core material (magenta channel) and shows a uniform distribution in the time series. Despite low partitioning and poor FUS-GFP retention (compare Supplementary Fig. 18 and 19), the final image shows colocalization of the FUS-GFP droplets and the core material (single channel images: Supplementary Fig. 9 and 10), indicating that p(A20-m/m*Atto647N) chains co-separate with the FUS-GFP condensates.

For the other samples, FUS-GFP PS progresses more slowly. This is not only due to chemical interactions, but also due to decreased core dynamics as identified by FRAP of all modified PN before MBP-FUS-GFP addition (Fig. 5f). m*Atto647N-PN (2) show a FRAP recovery with t1/2 = 1.4 s (FRAP details in Supplementary Note 9 and Supplementary Figs. 13, 14), whereas, in comparison, all other modified PN do not show any appreciable recovery in the same time frame. The reason for the low dynamics in the RNA-containing samples is the fact that the dangling RNA strand is in fact a hairpin that can also dimerize at high concentrations inside the PN instead of only folding intramolecularly in dilute solution (Supplementary Table 1, also containing NUPACK secondary structure simulations of dimers). In terms of structure formation, in m*-RNACy5-PN (3), the FUS-GFP condensates form in the center of the PN and do not show wetting of the inner surface of the shell as in pristine PN (1). In direct comparison to the m*Atto647N-PN (2), the addition of dangling RNA prevents leakage of the FUS-GFP condensates or formation of droplets at the outside of the shell. Overall, the retention of FUS-GFP after 5 h is much higher for the RNA-containing m*-RNACy5-PN (3) than for m*Atto647N-PN (2). The FUS-GFP condensates still behave dynamically as seen from the droplets merging from 5 h to 2 days, even though FUS-GFP and PN core material clearly form a combined phase. This observation is supported by FRAP measurements of the phase-separated droplets (Fig. 5g), showing a partial recovery of FUS-GFP after 1 day, while the core channel remains non-dynamic. This means that FUS-GFP condensate droplets can exchange RNA partners in the core, allowing for diffusion inside the PN core.

The remaining samples (4: T20Atto647N, 5: U20-RNACy5, 6: T20-mAtto647N) are dominated by slow PN core dynamics. In all cases the phase-separated FUS-GFP forms interconnected networks within the PN, which is an unusual behavior for the minority phase. It is a prime example of viscoelastic phase separation (VPS) known from polymer physics, which is caused by a dynamic asymmetry of two components in a mixture, here the long ssDNA in the PN core and FUS-GFP.54 This dynamic asymmetry leads to the slower phase sustaining mechanical stress, which results in the formation of network-like morphologies instead of droplets. For T20Atto647N-PN (4), the phase-separated structure remains arrested within two days, whereas for U20-RNACy5 (5) and T20-mAtto647N (6) PN, this VPS-network relaxes slowly over the span of two days. Here, the affinity of FUS-GFP to the PN material is strong enough to induce co-PS. This leads to vacuole formation, with the condensate being segregated to the PN shell. The formation of the concentric shell is due to affinity of the pA core material for the pT shell (A20/T20-duplexes stabilize the PN core shell interface; see Fig. 1a). The similarity in the final morphology compared to pristine PN (1) raises the question whether the pA core material of the pristine PN is segregated as well. Indeed, a covalently labeled p(A20-m)Atto425 shows a similar co-separation (Supplementary Fig. 20), which is also why we selected parameters in the numerical simulations (Fig. 4) to reflect this behavior. At first glance, this A20/T20-duplex driven morphology seems unique to PN, yet it bears some resemblance to nuclear organization in cells. Cell nuclei are organized by spatially segregated euchromatin and heterochromatin domains, with the latter located at the nuclear periphery. This structure results from tethering of heterochromatin to the nuclear lamina, which is anchored to the inner nuclear membrane.55,56 PN abstract this concentric organization in a minimalist model system.

In summary, FUS-GFP partitioning, PS timescale and condensate morphology are drastically influenced by the nucleic acid sequences present in the PN core. Simple sequence variations lead to the extremes of slowed down PS kinetics

(4: T20Atto647N), partial expulsion of FUS-GFP from the core (2: m*Atto647N) and full co-PS of FUS-GFP with the PN core material and segregation to the interface with vacuole formation (1: pristine, 5: U20-RNACy5, 6: T20-mAtto647N). Critically, classical EMSA affinity measurements largely fail to predict the partitioning behavior observed in our complex system. This disparity underscores a central insight of our study: Protein/nucleic acid affinity alone cannot predict polymer behavior in confined, crowded, and multivalently interacting PN environments. Instead, the dynamic and structural context in which these interactions occur plays a decisive role. The origin relates to the fact that the PN permits multimodal binding in a compact, electrostatically diverse space, instead of an isolated binary interaction. For instance, high affinity binders like m*-RNACy5 (3, Fig. 5e) cause strong multimodal binding which restricts the degrees of freedom of the protein by locking its orientation. In contrast to this restricted conformation, a weak binder will offer conformational freedom to the protein, allowing it to more dynamically interact with an environment phase and adapt to its constraints. We hypothesize that these weak, transient interactions provide a better environment for partitioning in crowded systems. While our results indicate intricate and complex interplays between many parameters, they clearly show that test-tube affinity measurements have limitations in replicating the processes in crowded DNA-rich environments, highlighting the importance of developing PN to better mimic intra-nuclear complexity.

FUS PS is controlled by PN core crosslinking

Next to tuning the composition, another key advantage of our PN platform is the ability to tune their dynamic and viscoelastic properties. This can be achieved by using a modified p(A20-m-XL) sequence, which contains a self-complementary region XL that forms crosslinks (Fig. 6 inset). Such linkers are known to profoundly impact the viscoelastic properties, as well-established for macroscopic DNA hydrogels.57,58 Mixing p(A20-m-XL) with p(A20-m) prior to the formation of the PN leads to co-assembly within the PN, allowing to fine-tune their composition. FRAP measurements after MBP-FUS-GFP partitioning reveal a great impact of the XL domain on PN dynamics (Supplementary Fig. 21). The characteristic t1/2 increases for higher p(A20-m-XL) fractions and the endpoint recovery (ER) decreases, confirming the intended decrease in PN core dynamics for higher XL amounts. Complementary to this quantitative mobility analysis, Fig. 6 shows a morphology progression over time. Together, these datasets offer a comparative analysis of the FUS PS dynamics upon PN core crosslinking.

Fig. 6. Crosslinking of PN influences FUS PS.

Fig. 6

Various degrees of crosslinking can be achieved by adding different fractions of p(A20-m-XL) to the PN (LR = 0.30). XL forms self-complementary crosslinks. Both highly crosslinked samples (75% and 100%) show some magenta speckles in the PN core, which originate from some shell aggregates present before TEV addition. The dashed square in the bottom right indicates a region of no visible PS within the optical limits of the microscope. A corresponding FRAP experiment is shown in Supplementary Fig. 21. Scale bars: 5 µm.

A clear trend emerges in how crosslinking affects FUS PS in PN after addition of TEV protease. Non-crosslinked, pristine PN with pure p(A20-m) display quick FUS PS and droplet formation that reorganizes over the course of 2 days to a concentric shell (same data as shown in Fig. 5c). These dynamics are greatly reduced when adding 25% p(A20-m-XL), which changes both the PS morphology and time progression. Grainy FUS PS is visible after 5 min, which only slightly coarsens during the next 3 days. Instead of localizing at the inner shell, a spongy and arrested phase-separated network occurs that originates from VPS.54 The basis for this behavior lies in the dynamic asymmetry created by the slower dynamics of the crosslinked core, as already discussed above (Fig. 5). The XL motifs impose additional connectivity within the PN core, thereby increasing the energetic and kinetic cost of redistributing the DNA core during FUS condensation. This restricts domain growth and relaxation, so that the 25% crosslinked sample remains trapped in a finely structured, spongy morphology rather than progressing toward larger, coarsened FUS-rich phases. A further increase of crosslinker leads to even slower dynamics. For 50% p(A20-m-XL), FUS PS is barely visible after 6 h and does not progress much over the next 3 days. Finally, at 75% crosslinking and above, no microscopically visible FUS PS occurs anymore over the span of 3 days. A quantitative analysis of the phase separation process is shown in Supplementary Fig. 22.

Viscoelastic environment suppresses FUS liquid-to-solid transitions

As commonly reported for FUS, condensates can age and undergo a liquid-to-solid transition over time.23,24,59–61 Our PN with tunable dynamics can help to understand how confinement can influence this behavior. FUS condensate liquid-to-solid transition is measurable by FRAP of the protein in buffer (droplet assay).23,62 Since FUS only shows PS after MBP cleavage, there is no direct reference sample for FRAP of the fully dissolved MBP-FUS-GFP state. As a substitution for this data point, we prepared a sample with 10% PEG as a molecular crowder which forces MBP-FUS-GFP PS even without MBP cleavage (Fig. 7a). The remaining data points after TEV addition are taken from a droplet assay without PEG and in presence of the low-molecular PN core sequence (A20-m)5 with m*-RNACy5. DNA and RNA have been added in the same amounts as for PN samples, with the difference of not being assembled into PN (see Supplementary Note 17; Supplementary Fig. 23). As expected, these samples show a strong decrease in FUS mobility already after 6 h in buffer on account of ongoing aging (Fig. 7a).

Fig. 7. FUS-GFP in PN retains partial mobility after 3 days.

Fig. 7

a FRAP measurements in the FUS-GFP channel in a droplet assay (left) versus 0% and 75% crosslinked PN samples (right) at different time points: After MBP-FUS-GFP addition (light purple and green line), and at different time points after TEV protease-induced PS (darker purple and green lines). For N ≥ 2, curves show the mean and shaded bands indicate the standard error. For N = 1, individual traces are shown. Droplet assay: N = 1, 1, 3, 2. PN 0% p(A20-m-XL): N = 4, 5, 3. PN 75% p(A20-m-XL): N = 5, 3, 4 (top to bottom). N denotes the number of individual FRAP measurements. b Scheme and c CLSM images showing FUS-GFP is drawn out of 75% XL-PN after addition of excess m*-RNACy5 to a 3 days old PN sample. Scale bars = 5 µm. Source data are provided as a Source Data file.

Having established these reference systems, we turn to the PN systems with FUS-GFP. The pristine p(A20-m)-PN without crosslinking show only a small consecutive decrease in the FRAP recovery profiles for FUS-GFP over time, whereas a clear decrease to before PS (MBP-FUS-GFP) is discernible (Fig. 7a). For PN with p(A20-m-XL)/p(A20-m) = 75/25, hence in a highly crosslinked state, the initial FRAP of FUS-GFP shows lower recovery dynamics due to the highly crosslinked nature of the PN. However, as time progresses, a further liquid-to-solid transition of FUS condensates is suppressed, as the decrease of the FRAP profiles is comparably little in highly cross-linked PN, as well as on the same level as to before PS (MBP-FUS-GFP) (Fig. 7a). This led us to conclude that both PS and aging of phase-separated FUS are suppressed by crosslinking.

To further underscore the dynamic properties of FUS-GFP in the 75% crosslinked PN, we added a two-fold excess of m*-RNACy5 to offer FUS-GFP a non-polymeric binder after 3 days of aging inside the PN (Fig. 7b). This control experiment is designed to discern liquid FUS from solid fractions, as we hypothesized that non-solidified FUS would interact and phase-separate with the dynamic nucleic acid binder. Over the course of a few hours, the m*-RNACy5 infiltrates the core of the aged, 75% crosslinked PN (Fig. 7c). However, because of the two-fold excess there is a large unbound fraction of m*-RNACy5 in solution, so that FUS-GFP condensates form at the PN–solution interface with only a low intensity in the green FUS channel remaining inside the PN. We suggest that the residual FUS-GFP in the PN core largely originates from the solid fraction, whereas the dynamic, RNA-bound fraction is leached out and forms condensates on the outer surface of the PN shell.

Taken together, the viscoelastic suppression of FUS-GFP PS also slows down the aberrant liquid-to-solid transition of the protein–a hallmark of disease. Hence, the viscoelastic properties are not only relevant to enter the domain of VPS (FUS network formation, although at binodal concentrations), but also to regulate the extent of FUS PS and its liquid-to-solid transition during aging. These results are instructive for possible therapeutic strategies, as they highlight the importance of the physical environment of membraneless organelles for aberrant phase transition and protein aggregation processes.

Discussion

This work has introduced protonuclei (PN)–programmable DNA-based nucleus-inspired compartments–as a versatile platform to study the impact of environmental constraints on the affinity, phase separation (PS), and liquid-to-solid phase transitions of nucleic acid-binding proteins. Our findings give a fresh perspective on how to interpret protein-nucleic acid interactions and PS in the context of more complex cell-like environments, here in particular the cell nucleus. While affinity-based assays remain useful, they fail to reflect the complex interplay of multivalency, confinement, and physical state that governs condensation in the nucleus. The PN system and future derivatives thereof have the potential to fill this gap, offering a controllable testbed that reveals how local context shapes condensate formation, retention, and aging. By mimicking essential features of the cell nucleus, including nucleic acid crowding, compositional heterogeneity, and tunable viscoelasticity, PN provide an intermediate between simplistic ex vivo test tube assays and complex cellular systems. Using FUS, a protein linked to neurodegenerative diseases, we demonstrate that its phase behavior inside PN is strongly influenced by the sequence and structure of nucleic acids, as well as by the dynamic mechanical properties of the DNA-rich core.

A central finding is the limited predictive power of solution-based protein-nucleic acid interaction assays, such as EMSA, which fail to capture the complex interactions arising in the multivalent and crowded PN environment. We show here that seemingly minor changes in nucleic acid sequence or mechanical constraints can have drastic effects on protein partitioning, phase morphology, and condensate dynamics. Moreover, by incorporating crosslinks into the PN core, we demonstrate how viscoelasticity can suppress PS and delay the liquid-to-solid transition during condensate agingpointing to a critical role of the physical environment in regulating phase behavior. The ability of PN to suppress PS or alter condensate morphology via crosslinking parallels how nuclear viscoelasticity regulates biological function in vivo. For instance, mechanical deformation during confined cell migration induces chromatin reorganization that can trigger condensate coalescence and de novo assembly.63 Furthermore, nuclear stiffness is dynamically tuned by chromatin compaction, which suppresses PS in stiff heterochromatin regions and allows PS in softer euchromatin regions. By using targeted condensation and stiffness gradients, it is assumed that cell nuclei can dynamically restructure their genomic loci.64 This modulation of nuclear PS in cells points to potential physical regulators of phase transitions beyond biochemical interactions. These insights support emerging views that pathological phase transitions may be mitigated not only by molecular inhibitors but also by targeting the mechanical properties of the nuclear environment.65

Looking ahead, the PN system in combination with numerical simulations offers a powerful framework to probe more complex nuclear PS phenomena. Its modularity allows incorporation of multiple proteins and nucleic acids, enabling studies of competition, cooperativity, and emergent behavior. The ability to systematically vary protein variants and nucleic acid sequences also opens up routes to explore disease-associated mutations and their impact on phase transitions in a nucleus-like environment. Additionally, future development of a theoretical model to predict protein PS in PN can be an insightful tool to identify the underlying molecular interactions governing partitioning, dynamics, morphology and PS suppression. Beyond structural observations, PN can be adapted to investigate the functional consequences of PS, for example on transcription or RNA processing. Given their synthetic nature and programmability, PN may also serve as bottom-up tools for screening condensate-modulating compounds, or as functional components in synthetic biology systems.

In the long term, the PN platform could aid in reconstituting complex, disease-relevant membraneless organelles under tunable conditions. This might allow systematic dissection of how disease-linked mutations, co-factors, or mechanical perturbations influence phase behavior–a task that remains challenging in live cells. As synthetic biology and condensate pharmacology advance, synthetic systems like PN may also help screen for compounds that modulate phase behavior not just by disrupting binding, but by altering the physical microenvironment. Altogether, our findings not only highlight the limitations of classical assays but also provide a blueprint for powerful ex vivo models. PN offer a rich design space to dissect the rules of intracellular PS and hold potential for guiding future therapeutic strategies targeting condensate dynamics in disease.66,67

Methods

Materials

Oligonucleotide strands were ordered as shown in Supplementary Table 1 from Integrated DNA Technologies (IDT) and Biomers. Enzymes phi29 DNA Polymerase (10 U μL─1), T4 DNA Ligase (2 U μL─1), Exonuclease I (20 U μL─1), Exonuclease III (200 U μL─1) were purchased from LGC Genomics. Thermostable inorganic pyrophosphatase (TIPP, 2000 U mL─1) and nuclease-free water were purchased from New England Biolabs (NEB), dNTPs (100 mM–110 mM) were purchased from Jena Bioscience. Sodium chloride (Gen-Apex) was purchased from VWR, magnesium chloride solution (2 M, BioUltra) was purchased from Sigma Aldrich, Invitrogen TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) was purchased from Thermo Fisher Scientific.

PN core and shell ssDNA synthesis

The procedure for rolling circle amplification of ssDNA polymers was adapted from our previous report.28 The stock solutions of 5′-phosphorylated templates and their corresponding ligation strand (Supplementary Table 1) were mixed in equimolar stoichiometry to attain a final concentration of 1 μM in TE buffer (Invitrogen; 10 mM Tris(hydroxymethyl)aminomethane pH = 8 and 1 mM EDTA) containing additionally 100 mM NaCl (total volume 100 μL). The concentrations of the strands are kept low to prevent inter-strand hybridizations. The buffered mixture was heated up to 85 °C (for 5 min) at a rate of 3 °C s─1 and slowly cooled down to 25 °C at 0.01 °C s─1. After annealing the strands, 20 μL of 10x commercial ligase buffer (LGC; 500 mM Tris-HCl, 100 mM MgCl2, 50 mM dithiothreitol, and 10 mM ATP), 70 μL of water, and 10 μL of T4 ligase (2 U μL─1) were added in the reaction tube containing 100 μL of the template strand, stirred (10 min, 400 rpm) and left to react for 3 h at 25 °C. The T4 ligase was then denatured by heating the reaction mixture for 20 min at 70 °C. Then 10 μL of exonuclease I (LGC; 20 U μL─1) and 10 μL of Exonuclease III (LGC; 200 U μL─1) were added, and the mixture was kept overnight at 37 °C on a thermo-shaker (Eppendorf) with gentle shaking (300 rpm) to digest unreacted ligation strands and non-circularized templates in solution. Then the exonucleases were subsequently deactivated by heating the reaction mixture at 80 °C for 40 min. The circular templates were purified using the Amicon Ultra-centrifugal filters with a 10 kDa cut-off (Merck Millipore) and washed three times using TE buffer over the same filter. The concentration of circular templates was measured by the use of a ScanDrop (Analytik Jena) spectrophotometer, and the solutions were diluted to 10 μM using TE buffer. To synthesize multiblock ssDNA polymers, 0.5 μL circular template (10 μM) were mixed with 10 μL of commercial 10x polymerase buffer (LGC; 500 mM Tris-HCl, 100 mM (NH4)2SO4, 40 mM dithiothreitol, 100 mM MgCl2), 1 μL of exonuclease-resistant primer (10 μM in TE buffer), 2 μL of Φ29 Polymerase (LGC; 10 U μL─1), 5 μL of pyrophosphatase (New England Biolabs; 2000 U mL─1), and 5 μL of an adjusted dNTP mixture (total dNTP concentration of 100 mM, the percentage of each base corresponds to the expected sequence composition in the ssDNA polymer), and 76.5 μL of ultrapure nuclease-free water. The reaction mixtures were kept at 30 °C for 60 h on a thermo-shaker with a gentle shaking (300 rpm). The solution containing ultralong ssDNA polymer was subjected to temperature-induced cleavage for 15 min at 95 °C, and the resulting solution was then washed through Amicon Ultra-centrifugal filters with a 30 kDa cut-off (Merck Millipore, three to four times) using 350 μL of TE buffer. The amount and purity of the ssDNA polymers were determined using a ScanDrop (Analytik Jena) spectrophotometer. The pyrophosphatase enzyme was added to prevent the formation of insoluble magnesium pyrophosphate as a side product that hinders the polymerization process and is also accountable for resulting in so-called nanoflowers and might cause misperception during the microscopic investigations.

Purification of MBP-FUS-EGFP-His6 and MBP-FUS-His6

Expression and purification of recombinant MBP-FUS-EGFP-His6 and MBP-FUS-His6 was performed as described in (Hofweber, Cell 2018)61. Briefly, BL21-DE3-Rosetta-LysS cells were transformed with a pMal-MBP-Flag-FUS-GFP-His6 or MBP-FUS-His6 expression plasmid and grown in standard lysogeny broth (LB) medium until OD (600 nm) value reached 0.8. Expression was induced with 0.1 mM IPTG for 22 h at 12 °C. Cells were lysed in lysis buffer (50 mM Na2HPO4/NaH2PO4 pH 8.0, 300 mM NaCl, 10 μM ZnSO4, 40 mM imidazole, 4 mM β-mercaptoethanol, 10% (v/v) glycerol and 1 μg/mL each aprotinin, leupeptin and pepstatin) using sonication. MBP-FUS-GFP-His6 or MBP-FUS-His6 were purified by tandem-affinity purification using Ni-NTA agarose (Qiagen) and amylose resin (NEB) and eluted in lysis buffer supplemented with 250 mM imidazole and 20 mM maltose for MBP-FUS-EGFP-His6, and 50 mM imidazole and 10 mM maltose for MBP-FUS-His6, respectively. Proteins were dialyzed against storage buffer (20 mM Na2HPO4/NaH2PO4, pH 8.0, 150 mM NaCl, 5% (v/v) glycerol, 1 mM EDTA, 1 mM DTT), snap-frozen in liquid N2 and stored at -80 °C. The OD260/280 ratio for MBP-FUS-EGFP-His6 was 0.74, and for MBP-FUS-His6 was 0.65.

His6-TEV protease purification

Expression and purification of His6-TEV was performed as described in (Hofweber, Cell 2018)61. Briefly, BL21-DE3 Rosetta-LysS cells were transformed with a pET24(+)-His-TEV plasmid and grown in standard lysogeny broth (LB) medium until OD (600 nm) value reached 0.7. Expression was induced with 0.5 mM IPTG for 20 h at 18 °C. Cells were lysed in lysis buffer (50 mM Tris pH 8, 200 mM NaCl, 20 mM imidazole, 10% (v/v) glycerol, 4 mM β-mercaptoethanol) in presence of 0.1 mg/mL RNase A using lysozyme and sonication. His6-TEV was purified using Ni-NTA agarose (QIAGEN) and eluted in lysis buffer containing 600 mM imidazole. The protein was dialyzed against storage buffer (50 mM Tris pH 8, 150 mM NaCl, 20% (v/v) glycerol, 2 mM DTT), snap-frozen in liquid N2 and stored at −80 °C.

PN formation

PN are formed as shown in Fig. 1a. The formation of PN is initiated by combining pA at 0.18 g/L and pT at 0.03 g/L in TE buffer, together with MgCl2 at a final concentration of 50 mM. A typical preparation would target a final volume of 65 μL in a PCR tube, which is enough for 6 experimental batches. The mixture is then subjected to a heating ramp to 95 °C for 20 min with a heating and cooling rate of 3 °C min─1. After cooling the sample is split up and 10 μL of the PN stock are added to a fresh PCR tube containing the respective dye-labeled DNA or RNA strands. Here, the DNA complementary to the shell (n*) is added in exact stoichiometry to the barcode concentration, whereas the core DNA or RNA (m*) is added at 0.8 equivalents relative to the concentration of the complementary core-binding sites to ensure there is none left in solution. After mixing with a pipette, the samples are allowed to equilibrate for 60 min while shaking at 400 rpm. In a final step the buffer is adjusted to FUS-nucleic acid binding buffer by 10x dilution with HEPES buffer (10 mM HEPES, 200 mM KCl, 1 mM DTT, 5 mM MgCl2, glycerol 3%, pH 7.5) in a well plate, yielding a final Mg2+ concentration of 9.5 mM. The PN are then allowed to swell and settle to the bottom of the plate, so that the volume can be carefully reduced with a pipette from the top to a working volume of 25 μL. During this process the plate is sealed to prevent evaporation; the seal is only lifted for further pipetting steps, e.g., TEV addition. Plates are generally stored at room temperature (25 °C) during all steps.

For crosslinked PN the specified fraction of pA was replaced by pA-XL with a self-complementary domain, but all other steps of the preparation remain the same.

Concentration-dependent PS experiments

PN were prepared as mentioned above, but without the addition of core-modifying DNA/RNA strands. In order to stay within the same PN batch for all experiments, half of the PN stock was stored at 4 °C for three days prior to use. We routinely observe PN stocks in high-salt buffer to be stable for weeks to months, highlighting their exceptional robustness. Imaging of the samples was done continuously for the first 30 min after TEV addition and again after 5 h. All images have been adjusted in contrast and brightness.

PN core modification experiments and crosslinking

A fresh aliquot of the MBP-FUS-GFP protein (45 μM) was thawed slowly on ice and mixed gently with a pipette. It was then added at a final concentration of 1.5 μM to the respective PN microplate well with a pipette and immediately mixed with a bigger volume pipette to ensure an even distribution. The protein was allowed to partition into the PN for 30–60 min at room temperature until completion of partitioning was confirmed via CLSM. Then a freshly thawed aliquot of TEV protease (80 μM) was mixed and added to the wells at a final concentration of 5 μM, marking the start of the PS process. After all additions were made, the plate was sealed to avoid evaporation within the timespan of the experiment.

Electrophoretic mobility shift assay (EMSA)

The nucleic acid sequences, modifications and suppliers can be found in Supplementary Table 1. Duplexes (m/m*Atto647N and A20/T20Atto647N) were annealed using one labeled strand and one unlabeled strand. 500 nM of labeled nucleotide probe were diluted in binding buffer (20 mM Na-Phosphate pH 7.5, 75 mM NaCl, 5 mM MgCl2, 2.5% glycerol, 1 mM DTT, 1 U/µL RNase inhibitor (Thermo Fisher)) and mixed with varying amounts of MBP-FUS-His6. Binding reactions (10 µL) were incubated for 1 h at RT and after addition of 2 µL 30% (v/v) glycerol, samples were loaded onto a 1 mm thick non-denaturing polyacrylamide gel (6%) in 0.5 × TBE. Gels were run at 100 V for 40 min at RT before imaging with a Bio-Rad ChemiDoc MP Imaging system.

Fluorescence recovery after photobleaching (FRAP)

All FRAP experiments were conducted on a Leica Stellaris 5 CLSM. The bleaching procedure involved the selection of an approximately 1–2 µm sized ROI in the center of a PN, which was bleached with the 488 nm or 638 nm laser at 100% intensity for 0.42 s. The recovery was followed in time intervals of 1 s per frame, which is a compromise between high sampling rate and avoidance of sample bleaching.

The data was processed and fitted with the Stowers FRAP plugin, using the batch FRAP fit jru v1 function. For intensity measurements only raw images are used. The plugin uses the following fitting function, which is the standard exponential FRAP fit.

It=b+A1−e−tτ 4

From this we obtain the baseline intensity b, the amplitude of the recovery curve A and the recovery time constant τ. From the fit results we obtain t1/2 and the mobile fraction M with the following calculations, which also involve the average pre-FRAP intensity p.

t1/2=τ×ln(2) 5
M=Ap−b 6

However, several FRAP traces do not reach a reliable plateau within the imaging window. In these cases, the recovery extent is quantified directly from the normalized fluorescence trace at the final recorded time point rather than from fit-derived mobile fractions. We report this value as the endpoint recovery ER.

A representative bleaching sequence, the placement of the bleaching and analysis ROIs, individual normalized recovery traces and an example of curve fitting are shown in Supplementary Fig. 13 and described in Supplementary Note 9.

Statistics & Reproducibility

Sample sizes were selected to include multiple protonuclei (PN), droplets or fluorescence recovery after photobleaching (FRAP) measurements per condition and to characterize variability between individual PN. No statistical method was used to predetermine sample size. Exact sample sizes and the corresponding units of analysis are stated in the figure legends. Unless stated otherwise, N denotes the number of individual PN compartments, droplets or FRAP regions analyzed. For microscopy experiments, multiple PN or regions of interest were imaged within the same sample. These compartment-level measurements represent distinct observations but not independent experimental batches. Time-series experiments followed multiple PN within the same sample over the indicated time course. Independent technical repeats are stated where performed. Representative images were selected from larger fields of view, which are provided in the Supplementary Information where applicable. The reported data and trends were consistently observed across multiple PN and different PN batches.

For quantitative microscopy analyses, PN outside the focal plane or not fully contained within the image frame were excluded. For the per-PN morphology analysis in Supplementary Fig. 22, small regions of interest representing peripheral optical sections through larger PN were also excluded, because these sections may appear homogeneous despite phase separation in the equatorial plane. No further data were excluded from the analyses. Data points outside the 1.5 × interquartile range whiskers were displayed as outliers but retained. Likewise, the LR = 0.90 FRAP dataset in Supplementary Fig. 5 was retained and displayed, although it was identified as deviating from the general trend. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment.

The analyses were descriptive, and no inferential statistical tests were performed. Consequently, no statistical P values or corrections for multiple comparisons are reported. Where replicate experimental measurements were averaged, variability is reported as the standard deviation or standard error unless stated otherwise. Diameter distributions are presented using the median, interquartile range and 1.5 × interquartile range whiskers, together with the mean. FRAP traces were normalized and averaged as indicated in the corresponding figure legends, with standard error shown as shaded regions. Average recovery curves were fitted using a single-exponential recovery function to determine the half-recovery time. When a reliable plateau was not reached, endpoint recovery was determined directly from the average trace. Microscopy data were analyzed using Fiji/ImageJ version 1.54p, and experimental numerical data were analyzed and visualized using OriginPro 2023 (version 10.0.0.154). For the molecular dynamics simulations, each DNA system comprised one continuous 1-µs trajectory and nine independent 100-ns replicate simulations. Replicate-derived end-to-end distances are reported as the mean ± standard error of the mean.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Supplementary information

Supplementary Movie 1 (41.8MB, mp4)
Supplementary Movie 2 (2.7MB, mp4)
Supplementary Movie 3 (19.8MB, mp4)
Reporting Summary (95.9KB, pdf)

Source data

Source Data (1.8MB, xlsx)

Acknowledgements

We would like to thank Prof. Dr. Miguel Andrade for his helpful discussions and Sára Varga for the provision of additional purified TEV and MBP.

Author contributions

D.D. and A.W. conceived and supervised the project. E.S. expressed and purified the protein. N.K. performed the EMSA experiments. J.F. planned and carried out all other experiments, performed data analysis, and was responsible for the majority of the experimental work. Numerical simulations were conducted by J.J.M., and all-atom MD simulations were performed by A.P. under the supervision of L.S. Initial experiments and early polymer synthesis were performed by A.S. J.F. and A.W. wrote the manuscript, with input from all authors.

Peer review

Peer review information

Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.

Funding

We acknowledge funding from CRC 1551 ‘Polymer Concepts in Cellular Function’ of the Deutsche Forschungsgemeinschaft (DFG project number 464588647). A.S. acknowledges support through a postdoctoral grant of the Alexander von Humboldt Foundation. D.D. acknowledges funding by the DFG Heisenberg program (DFG project number 442698351). E.S. was supported by a Peter and Traudl Engelhorn Postdoctoral Fellowship. Parts of this research were conducted using the supercomputer MOGON 2 and/or advisory services offered by Johannes Gutenberg University Mainz (hpc.uni-mainz.de), which is a member of the AHRP (Alliance for High Performance Computing in Rhineland Palatinate, www.ahrp.info) and the Gauss Alliance e.V. The authors gratefully acknowledge the computing time granted on the supercomputer MOGON 2 at Johannes Gutenberg University Mainz (hpc.uni-mainz.de). Open Access funding enabled and organized by Projekt DEAL.

Data availability

The numerical source data underlying all graphs and charts in the Article and Supplementary Information, including individual experimental measurements, FRAP fluorescence trajectories and fit outputs, and numerical outputs underlying the computational analyses, together with uncropped EMSA gel images, are provided with this paper. The complete raw confocal microscopy dataset is not publicly deposited because it comprises a large collection of instrument-native, multichannel and time-resolved files with associated acquisition metadata. These files are available from the corresponding author, Andreas Walther (andreas.walther@uni-mainz.de), upon request. Requests will be acknowledged within seven days and the data will be supplied via file transfer within 30 days. All other data supporting the findings of this study are available within the Article and its Supplementary Information. Source data are provided with this paper.

Code availability

The custom Fiji macro used for the quantitative analysis of FUS-rich area fractions and fluorescence-intensity variation is provided with this paper as Supplementary Software 1. The macro is supplied as a plain-text ImageJ macro file and includes instructions regarding the required input format, analysis parameters and generated outputs. The scripts underlying the all-atom molecular dynamics simulations in Supplementary Note 11 are available on Zenodo68 (https://doi.org/10.5281/zenodo.21906666). The code underlying the phase field simulations is available from corresponding author J.J.M. upon request. The code used for this work is an integral part of a larger in-house development including many additional functions and routines that are not (yet) publicly available. Extracting the code relevant to the Nat. Commun. paper is a significant effort, which will only be undertaken upon request. Requests will be acknowledged within seven days and the code used in this study will be supplied via file transfer within 30 days.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Jasper J. Michels, Email: michels@mpip-mainz.mpg.de

Dorothee Dormann, Email: ddormann@uni-mainz.de.

Andreas Walther, Email: andreas.walther@uni-mainz.de.

Supplementary information

The online version contains supplementary material available at https://doi.org/10.1038/s41467-026-78144-1.

References

  • 1.Hyman, A. A., Weber, C. A. & Jülicher, F. Liquid-liquid phase separation in biology. Annu. Rev. Cell Dev. Biol.30, 39–58 (2014). [DOI] [PubMed] [Google Scholar]
  • 2.Banani, S. F., Lee, H. O., Hyman, A. A. & Rosen, M. K. Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol.18, 285–298 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Boeynaems, S. et al. Protein phase separation: a new phase in cell biology. Trends Cell Biol.28, 420–435 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hirose, T., Ninomiya, K., Nakagawa, S. & Yamazaki, T. A guide to membraneless organelles and their various roles in gene regulation. Nat. Rev. Mol. Cell Biol.24, 288–304 (2023). [DOI] [PubMed] [Google Scholar]
  • 5.Strom, A. R. & Brangwynne, C. P. The liquid nucleome – phase transitions in the nucleus at a glance. J. Cell Sci.132, jcs235093 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Alberti, S., Gladfelter, A. & Mittag, T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell176, 419–434 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ghosh, A., Mazarakos, K. & Zhou, H.-X. Three archetypical classes of macromolecular regulators of protein liquid–liquid phase separation. Proc. Natl. Acad. Sci. U.S.A.116, 19474–19483 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.André, A. A. M. & Spruijt, E. Liquid–liquid phase separation in crowded environments. Int. J. Mol. Sci.21, 5908 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marianelli, A. M., Miller, B. M. & Keating, C. D. Impact of macromolecular crowding on RNA/spermine complex coacervation and oligonucleotide compartmentalization. Soft Matter14, 368–378 (2018). [DOI] [PubMed] [Google Scholar]
  • 10.Schuster, B. S. et al. Controllable protein phase separation and modular recruitment to form responsive membraneless organelles. Nat. Commun.9, 2985 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.André, A. A. M., Yewdall, N. A. & Spruijt, E. Crowding-induced phase separation and gelling by co-condensation of PEG in NPM1-rRNA condensates. Biophys. J.122, 397–407 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kaur, T. et al. Molecular crowding tunes material states of ribonucleoprotein condensates. Biomolecules9, 71 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Alberti, S. & Dormann, D. Liquid–liquid phase separation in disease. Annu. Rev. Genet.53, 171–194 (2019). [DOI] [PubMed] [Google Scholar]
  • 14.Boija, A., Klein, I. A. & Young, R. A. Biomolecular Condensates and Cancer. Cancer Cell39, 174–192 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Carey, J. L. & Guo, L. Liquid-liquid phase separation of TDP-43 and FUS in physiology and pathology of neurodegenerative diseases. Front. Mol. Biosci. 9, 826719 (2022). [DOI] [PMC free article] [PubMed]
  • 16.Mackenzie, I. R., Rademakers, R. & Neumann, M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol.9, 995–1007 (2010). [DOI] [PubMed] [Google Scholar]
  • 17.Levone, B. R. et al. FUS-dependent liquid–liquid phase separation is important for DNA repair initiation. J. Cell Biol.220, e202008030 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Samanta, A., Baranda Pellejero, L., Masukawa, M. & Walther, A. DNA-empowered synthetic cells as minimalistic life forms. Nat. Rev. Chem.8, 454–470 (2024). [DOI] [PubMed] [Google Scholar]
  • 19.Merindol, R., Loescher, S., Samanta, A. & Walther, A. Pathway-controlled formation of mesostructured all-DNA colloids and superstructures. Nat. Nanotechnol.13, 730–738 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ludwanowski, S., Samanta, A., Loescher, S., Barner-Kowollik, C. & Walther, A. A modular fluorescent probe for viscosity and polarity sensing in DNA hybrid mesostructures. Adv. Sci.8, 2003740 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Liu, W., Samanta, A., Deng, J., Akintayo, C. O. & Walther, A. Mechanistic insights into the phase separation behavior and pathway-directed information exchange in all-DNA droplets. Angew. Chem.134, e202208951 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen, W., Fritzen, J. & Walther, A. Phase separation of nucleic acids: mechanisms, properties, and applications. Angew. Chem. Int. Ed.65, e23943 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Patel, A. et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell162, 1066–1077 (2015). [DOI] [PubMed] [Google Scholar]
  • 24.Wang, J. et al. A molecular grammar governing the driving forces for phase separation of prion-like RNA binding proteins. Cell174, 688–699.e16 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Loughlin, F. E. et al. The solution structure of FUS bound to RNA reveals a bipartite mode of RNA recognition with both sequence and shape specificity. Mol. Cell73, 490–504.e6 (2019). [DOI] [PubMed] [Google Scholar]
  • 26.Ganser, L. R. et al. The roles of FUS-RNA binding domain and low complexity domain in RNA-dependent phase separation. Structure.32, 177–187.e5 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Samanta, A., Sabatino, V., Ward, T. R. & Walther, A. Functional and morphological adaptation in DNA protocells via signal processing prompted by artificial metalloenzymes. Nat. Nanotechnol.15, 914–921 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Samanta, A., Hörner, M., Liu, W., Weber, W. & Walther, A. Signal-processing and adaptive prototissue formation in metabolic DNA protocells. Nat. Commun.13, 3968 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Liu, W., Lupfer, C., Samanta, A., Sarkar, A. & Walther, A. Switchable hydrophobic pockets in DNA protocells enhance chemical conversion. J. Am. Chem. Soc.145, 7090–7094 (2023). [DOI] [PubMed] [Google Scholar]
  • 30.Jutzi, D. et al. Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis. Nat. Commun.11, 6341 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Deng, H., Gao, K. & Jankovic, J. The role of FUS gene variants in neurodegenerative diseases. Nat. Rev. Neurol.10, 337–348 (2014). [DOI] [PubMed] [Google Scholar]
  • 32.Ratti, A. & Buratti, E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem.138, 95–111 (2016). [DOI] [PubMed] [Google Scholar]
  • 33.Dormann, D. & Haass, C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol. Cell. Neurosci.56, 475–486 (2013). [DOI] [PubMed] [Google Scholar]
  • 34.Kamelgarn, M. et al. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay. Proc. Natl. Acad. Sci. U.S.A.115, E11904–E11913 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dormann, D. et al. ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J.29, 2841–2857 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dormann, D. et al. Arginine methylation next to the PY-NLS modulates transportin binding and nuclear import of FUS. EMBO J.31, 4258–4275 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Brelstaff, J. et al. Transportin1: a marker of FTLD-FUS. Acta Neuropathol.122, 591–600 (2011). [DOI] [PubMed] [Google Scholar]
  • 38.Emmanouilidis, L. et al. A solid beta-sheet structure is formed at the surface of FUS droplets during aging. Nat. Chem. Biol.20, 1044–1052 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shen, Y. et al. The liquid-to-solid transition of FUS is promoted by the condensate surface. Proc. Natl. Acad. Sci. U.S.A.120, e2301366120 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.He, C., Wu, C. Y., Li, W. & Xu, K. Multidimensional super-resolution microscopy unveils nanoscale surface aggregates in the aging of FUS condensates. J. Am. Chem. Soc.145, 24240–24248 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Knowles, T. P. J., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol.15, 384–396 (2014). [DOI] [PubMed] [Google Scholar]
  • 42.Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol.19, 755–773 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dobson, C. M., Knowles, T. P. J. & Vendruscolo, M. The amyloid phenomenon and its significance in biology and medicine. Cold Spring Harb. Perspect. Biol.12, a033878 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Flory, P. J. Thermodynamics of High Polymer Solutions. J. Chem. Phys.10, 51–61 (1942). [Google Scholar]
  • 45.Huggins, M. L. Some Properties of Solutions of Long-chain Compounds. J. Phys. Chem.46, 151–158 (1942). [Google Scholar]
  • 46.Tompa, H. Phase relationships in polymer solutions. Trans. Faraday Soc.45, 1142–1152 (1949). [Google Scholar]
  • 47.Scott, R. L. The thermodynamics of high polymer solutions. V. phase equilibria in the ternary system: polymer 1—polymer 2—solvent. J. Chem. Phys.17, 279–284 (1949). [Google Scholar]
  • 48.Schaefer, C., Michels, J. J. & van der Schoot, P. Structuring of thin-film polymer mixtures upon solvent evaporation. Macromolecules49, 6858–6870 (2016). [Google Scholar]
  • 49.de Bruijn, R., Darhuber, A. A., Michels, J. J. & van der Schoot, P. Structuring in thin films during meniscus-guided deposition. J. Chem. Phys.161, 194709 (2024). [DOI] [PubMed] [Google Scholar]
  • 50.Strohm, L. et al. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD–associated UBQLN2 mutants. Life Sci. Alliance5, e202101327 (2022). [DOI] [PMC free article] [PubMed]
  • 51.Alberts, B. et al. Molecular Biology of the Cell. (Garland Science, 2002).
  • 52.Mills, J. B., Vacano, E. & Hagerman, P. J. Flexibility of single-stranded DNA: use of gapped duplex helices to determine the persistence lengths of Poly(dT) and Poly(dA). J. Mol. Biol.285, 245–257 (1999). [DOI] [PubMed] [Google Scholar]
  • 53.Grotz, K. K. et al. Dispersion correction alleviates dye stacking of single-stranded DNA and RNA in simulations of single-molecule fluorescence experiments. J. Phys. Chem. B122, 11626–11639 (2018). [DOI] [PubMed] [Google Scholar]
  • 54.Tanaka, H. Viscoelastic phase separation in biological cells. Commun. Phys.5, 1–12 (2022). [Google Scholar]
  • 55.van Steensel, B. & Belmont, A. S. Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression. Cell169, 780–791 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Falk, M. et al. Heterochromatin drives compartmentalization of inverted and conventional nuclei. Nature570, 395–399 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Merindol, R., Delechiave, G., Heinen, L., Catalani, L. H. & Walther, A. Modular design of programmable mechanofluorescent DNA hydrogels. Nat. Commun.10, 528 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Yue, L., Wang, S., Wulf, V. & Willner, I. Stiffness-switchable DNA-based constitutional dynamic network hydrogels for self-healing and matrix-guided controlled chemical processes. Nat. Commun.10, 4774 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Monahan, Z. et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J.36, 2951–2967 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Qamar, S. et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-π interactions. Cell173, 720–734.e15 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Hofweber, M. et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell173, 706–719.e13 (2018). [DOI] [PubMed] [Google Scholar]
  • 62.Boczek, E. E. et al. HspB8 prevents aberrant phase transitions of FUS by chaperoning its folded RNA-binding domain. eLife10, e69377 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Zhao, J. Z., Xia, J. & Brangwynne, C. P. Chromatin compaction during confined cell migration induces and reshapes nuclear condensates. Nat. Commun.15, 9964 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shin, Y. et al. Liquid nuclear condensates mechanically sense and restructure the genome. Cell175, 1481–1491.e13 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lee, D. S. W., Strom, A. R. & Brangwynne, C. P. The mechanobiology of nuclear phase separation. APL Bioeng.6, 021503 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Mitrea, D. M., Mittasch, M., Gomes, B. F., Klein, I. A. & Murcko, M. A. Modulating biomolecular condensates: a novel approach to drug discovery. Nat. Rev. Drug Discov.21, 841–862 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Jeon, S. et al. Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets. Signal Transduct. Target. Ther.10, 1–42 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Preuß, A. FUS-RGG2-ssDNA molecular dynamics trajectories and analysis. Zenodo 10.5281/zenodo.21906666 (2026). [DOI]
  • 69.Michels, J. J., Brzezinski, M., Scheidt, T., Lemke, E. A. & Parekh, S. H. Role of solvent compatibility in the phase behavior of binary solutions of weakly associating multivalent polymers. Biomacromolecules23, 349–364 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Brzezinski, M. et al. Protein-specific crowding accelerates aging in protein condensates. Biomacromolecules26, 2060–2075 (2025). [DOI] [PubMed] [Google Scholar]
  • 71.Michels, J. J., Caria, J. & Lemke, E. A. A unifying thermodynamic model for phase separation and aging of biopolymers. Adv. Sci. e76691 10.1002/advs.76691 (2026). [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Movie 1 (41.8MB, mp4)
Supplementary Movie 2 (2.7MB, mp4)
Supplementary Movie 3 (19.8MB, mp4)
Reporting Summary (95.9KB, pdf)
Source Data (1.8MB, xlsx)

Data Availability Statement

The numerical source data underlying all graphs and charts in the Article and Supplementary Information, including individual experimental measurements, FRAP fluorescence trajectories and fit outputs, and numerical outputs underlying the computational analyses, together with uncropped EMSA gel images, are provided with this paper. The complete raw confocal microscopy dataset is not publicly deposited because it comprises a large collection of instrument-native, multichannel and time-resolved files with associated acquisition metadata. These files are available from the corresponding author, Andreas Walther (andreas.walther@uni-mainz.de), upon request. Requests will be acknowledged within seven days and the data will be supplied via file transfer within 30 days. All other data supporting the findings of this study are available within the Article and its Supplementary Information. Source data are provided with this paper.

The custom Fiji macro used for the quantitative analysis of FUS-rich area fractions and fluorescence-intensity variation is provided with this paper as Supplementary Software 1. The macro is supplied as a plain-text ImageJ macro file and includes instructions regarding the required input format, analysis parameters and generated outputs. The scripts underlying the all-atom molecular dynamics simulations in Supplementary Note 11 are available on Zenodo68 (https://doi.org/10.5281/zenodo.21906666). The code underlying the phase field simulations is available from corresponding author J.J.M. upon request. The code used for this work is an integral part of a larger in-house development including many additional functions and routines that are not (yet) publicly available. Extracting the code relevant to the Nat. Commun. paper is a significant effort, which will only be undertaken upon request. Requests will be acknowledged within seven days and the code used in this study will be supplied via file transfer within 30 days.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES